Vimarsana
Biggest News Aggregation in the World

Focused Drug Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Focused Drug Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Focused Drug Development Today - Breaking & Trending Today

American College of Cardiology (ACC) Program Set for Cardiac Oncology Conference, "Advancing the Cardiovascular Care of the Oncology Patient" - Vimarsana News

American College of Cardiology (ACC) Program Set for Cardiac Oncology Conference, "Advancing the Cardiovascular Care of the Oncology Patient"

Published: February 2, 2024

The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient,” will be held at the Heart House in Washington, D.C., Feb. 9-11, 2024. The event is offered as an interdisciplinary and interspecialty course with a robust program providing clinicians and researchers with the tools needed to improve the cardiovascular (CV) health of cancer patients in everyday practice.

Source: dicardiology.com
Related Topics:
United StatesUniversity Of WashingtonRichard ChengNicolas PalaskasRonald WittelesAlana FerrariAsma DilawariBonnie KyDaniel AddisonLova SunEric YangVivek NarayanJulia MauesAlexi VasbinderDanielle ShaferStephanie DixonLaleh Amiri KordestaniOncology ProgramUniversity Of PennsylvaniaPerelman School Of MedicineAmerican College Of CardiologyPanel DiscussionDrug AdministrationDrug DevelopmentAmerican College Of Cardiology Cardiac Oncology Conference
Submitting Patient-Reported Outcome Data in Cancer Clinical Trials - Vimarsana News

Submitting Patient-Reported Outcome Data in Cancer Clinical Trials

Published: November 3, 2023

Submitting Patient-Reported Outcome Data in Cancer Clinical Trials

Source: fda.gov
Related Topics:
Drug DevelopmentOncology CenterDrug AdministrationGuidance Issuing OfficeDocket NumberDrug EvaluationFocused Drug DevelopmentCore Patient Reported OutcomesCancer Clinical Trials
Mind Medicine MindMed : Company Logo MindMed Investor Presentation August 2023 - Vimarsana News

Mind Medicine MindMed : Company Logo MindMed Investor Presentation August 2023

Published: August 14, 2023

Company Logo MindMed Investor Presentation August 2023 Disclaimer This presentation has been prepared by Mind Medicine Inc. solely for informational purposes. None of... -Today at 05:35 pm- MarketScreener

Source: marketscreener.com
Related Topics:
United StatesPeter MackSchond GreenwayMark SullivanMiri Halperin WernliRobert BarrowFrancois LilienthalDaniel KarlinClinical Research In Psychiatric DisordersA Global Leader In Brain HealthDiagnosable Mental Health DisorderPrograms Portfolio OfficeResearch DevelopmentHead Of Development Carole AbelLsd Company Logo Mindmed Investor PresentationMindmed CompanyResearch Development Pipeline OurExchange CommissionPreclinical ResearchOur Rd Leadership TeamMedicine Mindmed IncApproval Research SurveillanceCollaborations Aim To Accelerate Discovery DevelopmentGlobal Regulatory Affairs Robert SilvaCompany Logo Mind Med Investor Presentation
Xtalks Announces its Life Science Webinar Calendar for June 2023 - Vimarsana News

Xtalks Announces its Life Science Webinar Calendar for June 2023

Published: June 2, 2023

Toronto, ON (PRWEB) June 02, 2023 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical

Source: prweb.com
Related Topics:
Population HealthPractices In Clinical Gene Therapy Method DevelopmentPrecision Research Ecosystem For RealHoneycomb Worldwide IncTb Vaccine DevelopmentOptimal Cell Line DevelopmentCart Development ProgramsInnovative TechnologyBuilding In SolutionsGlobal Regulatory Challenges In CoPreclinical DevelopmentDigital Pathology In Preclinical Rd ServicesManufacturers When Selectinga Lab Testing PartnerDrug DevelopmentClinical Trial Assay Development For Precision MedicineStage DevelopmentStatistical Computing SolutionsTrial Assay DevelopmentPrecision MedicineDiagnostics ExpertsInvasive ApproachesGene Therapy TrialsClinical TrialsEffective StrategiesBest Practices
Lumos Pharma to Participate in World Orphan Drug Congress USA - Vimarsana News

Lumos Pharma to Participate in World Orphan Drug Congress USA

Published: May 22, 2023

AUSTIN, Texas, May 22, 2023 -- Lumos Pharma, Inc. , a biopharmaceutical company advancing an oral therapeutic candidate for idiopathic Pediatric Growth Hormone Deficiency through Phase 2 clinical... | May 22, 2023

Source: marketscreener.com
Related Topics:
United StatesLisa MillerLumos PharmaJohn MckewAaron SchuchartLumos Pharma IncPractices On Patient GroupWorld Orphan Drug Congress United StatesPatient Focused Drug DevelopmentWorld Orphan Drug CongressPediatric Growth Hormone DeficiencyChief Scientific OfficerChief Business OfficerFocused Drug DevelopmentPatient GroupDrug Developer Interaction WithRare Disease SpaceIndustry PerspectivesWorld Orphan DrugOrphan Drug DesignationMedia ContactNc Stock ExchangePress ReleaseT Lumo Us55028x1090